Slight error: it adds an amino acid to the chain. The chain itself is/will fold into a protein.
The article does explicitly call it a "cancer vaccine" (direct quote from the researcher) and says "the same principle [as the COVID-19 vaccine] can be applied to get the immune system to take on tumours".
That's more specific than sneaking in with mRNA to get the body to produce something. It definitely sounds like whatever it is, it gets the immune system involved. It seems fair to ask exactly how it does this.
https://en.m.wikipedia.org/wiki/Pembrolizumab
The promise of mRNA is the potential to prompt the body to produce the therapeutic antibodies itself, rather than produce them externally and injecting regularly.
No, it really isn't more than that. You could send mRNA code into the body that produces a designer antibody that is specific to the cancer a patient has (similar to CAR-T, Keytruda, etc.), or you could design mRNA that specifically causes cancer cells to express antigens that attract the immune system. I'm obviously oversimplifying a pinnacle of human achievement, but on paper it should work that way.
If you can find specific sites, you can design a complimentary piece of RNA code to bind it and allow the drug delivery mechanism to do it's thing. Way fewer side effects versus systemic delivery.
So basically the mRNA tech is a means of delivering protein blueprints for in vivo production using your bodies natural machinery. In the case of COVID-19, this was used to manufacture spike protein, which attracts the body's immune response.
I'm not an expert on the best way to use the tech with cancer, but I could imagine a number of different approaches - targeted inducing of cell death, "painting the target" for chemo drugs, making things like monoclonal (designer) antibodies in-vivo, etc. The silver bullet is that it eliminates all of the complexity of creating and storing advanced biologics outside the body. Now you just deliver a bit of code and your body does it's thing.